CONMED CORPORATION (CNMD) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-09-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-09-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-09-30..
Borrowing debt
Overview →Financial period ending 2019-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 13.48M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 780.69M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.76B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | (m) | (m) | $13.48M | $780.69M | (m) | (m) | $1.76B | (m) |
| 2019-06-30 | (m) | (m) | $13.52M | $796.15M | (m) | (m) | $1.76B | (m) |
| 2019-03-31 | (m) | (m) | $14.38M | $803.55M | (m) | (m) | $1.76B | (m) |
| 2018-12-31 | (m) | (m) | $18.34M | $438.56M | (m) | (m) | $1.37B | (m) |
| 2018-09-30 | (m) | (m) | $18.05M | $442.90M | (m) | (m) | $1.36B | (m) |
| 2018-06-30 | (m) | (m) | $16.95M | $432.24M | (m) | (m) | $1.36B | (m) |
| 2018-03-31 | (m) | (m) | $15.79M | $442.41M | (m) | (m) | $1.35B | (m) |
| 2017-12-31 | (m) | (m) | $14.70M | $471.74M | (m) | (m) | $1.36B | (m) |
| 2017-09-30 | (m) | (m) | $13.54M | $494.79M | (m) | (m) | $1.36B | (m) |
| 2017-06-30 | (m) | (m) | $12.45M | $484.03M | (m) | (m) | $1.34B | (m) |
| 2017-03-31 | (m) | (m) | $11.30M | $487.05M | (m) | (m) | $1.33B | (m) |
| 2016-12-31 | (m) | (m) | $10.20M | $488.29M | (m) | (m) | $1.33B | (m) |
| 2016-09-30 | (m) | (m) | $10.14M | $490.18M | (m) | (m) | $1.33B | (m) |
| 2016-06-30 | (m) | (m) | $10.14M | $508.64M | (m) | (m) | $1.34B | (m) |
| 2016-03-31 | (m) | (m) | $10.09M | $511.60M | (m) | (m) | $1.34B | (m) |
| 2015-12-31 | (m) | (m) | $1.34M | $269.47M | (m) | (m) | $1.11B | (m) |
| 2015-09-30 | (m) | (m) | $1.28M | $260.55M | (m) | (m) | $1.09B | (m) |
| 2015-06-30 | (m) | (m) | $1.28M | $258.55M | (m) | (m) | $1.09B | (m) |
| 2015-03-31 | (m) | (m) | $1.23M | $257.20M | (m) | (m) | $1.09B | (m) |
| 2014-12-31 | (m) | (m) | $1.23M | $240.20M | (m) | (m) | $1.10B | (m) |
| 2014-09-30 | (m) | (m) | $1.19M | $246.83M | (m) | (m) | $1.11B | (m) |
| 2014-06-30 | (m) | (m) | $1.19M | $244.83M | (m) | (m) | $1.10B | (m) |
| 2014-03-31 | (m) | (m) | $1.14M | $241.44M | (m) | (m) | $1.08B | (m) |
| 2013-12-31 | (m) | (m) | $1.14M | $214.44M | (m) | (m) | $1.09B | (m) |
| 2013-09-30 | (m) | (m) | $1.09M | $224.02M | (m) | (m) | $1.08B | (m) |
| 2013-06-30 | (m) | (m) | $1.09M | $233.02M | (m) | (m) | $1.08B | (m) |
| 2013-03-31 | (m) | (m) | $1.05M | $224.80M | (m) | (m) | $1.08B | (m) |
| 2012-12-31 | (m) | (m) | $1.05M | $160.80M | (m) | (m) | $1.08B | (m) |
| 2012-09-30 | (m) | (m) | $1.01M | $168.44M | (m) | (m) | $1.09B | (m) |
| 2012-06-30 | (m) | (m) | $22.53M | $145.44M | (m) | (m) | $1.06B | (m) |
| 2012-03-31 | (m) | (m) | $54.22M | $138.95M | (m) | (m) | $1.08B | (m) |
| 2011-12-31 | (m) | (m) | $54.56M | $88.95M | (m) | (m) | $935.59M | (m) |
| 2011-09-30 | (m) | (m) | $166.38M | $9.12M | (m) | (m) | $999.19M | (m) |
| 2011-06-30 | (m) | (m) | $144.06M | $30.64M | (m) | (m) | $1.00B | (m) |
| 2010-12-31 | (m) | (m) | $110.43M | $85.18M | (m) | (m) | $985.77M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |